Literature DB >> 17379405

Bone marrow stromal cells induce changes in pain behavior after sciatic nerve constriction.

Patricia Leonor Musolino1, María Florencia Coronel, Tomas Hökfelt, Marcelo José Villar.   

Abstract

Peripheral nerve injury, i.e. a single ligature nerve constriction (SLNC), triggers neuropathic pain. Bone marrow stromal cells (MSCs) have been observed to migrate to the injured tissues and mediate functional recovery following brain, spinal cord and peripheral nerve lesions. We have recently shown MSC selective migration to the ipsilateral lumbar (L3-6) dorsal root ganglia (DRGs) after a sciatic nerve SLNC. In this study, we have analyzed the thermal and mechanical sensitivities of animals subjected to a SLNC of the sciatic nerve and an ipsilateral intraganglionic MSC injection, using the von Frey and Choi tests. Control animals were subjected to the nerve lesion either alone or followed by the administration of phosphate-buffered saline (PBS) or bone marrow non-adherent mononuclear cells (BNMCs). All the animals were tested both before surgery and after 1, 3, 7, 14, 21, 28 and 56 days. Animals subjected to the sciatic nerve constriction developed ipsilateral mechanical and thermal allodynia already 3 days after the lesion. The allodynic responses were maintained even after 56 days. MSC administration prevented the generation of mechanical allodynia and reduced the number of allodynic responses to cold stimuli. On the contrary, the injection of either PBS or BNMCs could not counteract allodynia. These results suggest that MSCs may modulate pain generation after sciatic nerve constriction. The underlying mechanisms by which MSCs exert their actions on pain behavior need to be clarified.

Entities:  

Mesh:

Year:  2007        PMID: 17379405     DOI: 10.1016/j.neulet.2007.03.001

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain.

Authors:  Wei Guo; Hu Wang; Shiping Zou; Ming Gu; Mineo Watanabe; Feng Wei; Ronald Dubner; George T-J Huang; Ke Ren
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

Review 2.  Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain.

Authors:  Temugin Berta; Yawar Qadri; Ping-Heng Tan; Ru-Rong Ji
Journal:  Expert Opin Ther Targets       Date:  2017-05-16       Impact factor: 6.902

3.  Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion.

Authors:  Gang Chen; Chul-Kyu Park; Rou-Gang Xie; Ru-Rong Ji
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

4.  IMT504 blocks allodynia in rats with spared nerve injury by promoting the migration of mesenchymal stem cells and by favoring an anti-inflammatory milieu at the injured nerve.

Authors:  Mailín Casadei; Esteban Fiore; Julia Rubione; Luciana María Domínguez; María Florencia Coronel; Candelaria Leiguarda; Mariana García; Guillermo Mazzolini; Marcelo J Villar; Alejandro Montaner; Luis Constandil; E Alfonso Romero-Sandoval; Pablo R Brumovsky
Journal:  Pain       Date:  2021-09-15       Impact factor: 7.926

5.  Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Nicola Alessio; Giovanni Di Bernardo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Cell Mol Life Sci       Date:  2009-11-24       Impact factor: 9.261

6.  Intrathecal Injection of Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorates Neuropathic Pain in Rats.

Authors:  Chunxiu Chen; Fengfeng Chen; Chengye Yao; Shaofang Shu; Juan Feng; Xiaoling Hu; Quan Hai; Shanglong Yao; Xiangdong Chen
Journal:  Neurochem Res       Date:  2016-09-21       Impact factor: 3.996

7.  Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy.

Authors:  Paola Sacerdote; Stefania Niada; Silvia Franchi; Elena Arrigoni; Alice Rossi; Vijay Yenagi; Laura de Girolamo; Alberto Emilio Panerai; Anna Teresa Brini
Journal:  Stem Cells Dev       Date:  2013-01-09       Impact factor: 3.272

8.  Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Authors:  Dario Siniscalco; Catia Giordano; Umberto Galderisi; Livio Luongo; Vito de Novellis; Francesco Rossi; Sabatino Maione
Journal:  Front Integr Neurosci       Date:  2011-12-01

Review 9.  Stem Cell Therapy for Modulating Neuroinflammation in Neuropathic Pain.

Authors:  Hari Prasad Joshi; Hyun-Jung Jo; Yong-Ho Kim; Seong-Bae An; Chul-Kyu Park; Inbo Han
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

10.  Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: safety, feasibility and preliminary clinical findings.

Authors:  Offer Zeira; Nimrod Asiag; Marina Aralla; Erica Ghezzi; Letizia Pettinari; Laura Martinelli; Daniele Zahirpour; Maria Pia Dumas; Davide Lupi; Simone Scaccia; Martin Konar; Carlo Cantile
Journal:  J Neuroinflammation       Date:  2015-09-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.